apixaban

Eliquis · ATC code B01AF02

Brand names: Eliquis, Abatixent, Elihib, Picsava, Sewab, Abidalo, Akkirateron, Axipio, Embavi, Treftenin, Apaclot, Apelto, Apivora, Apixelis, Apixenta …

Key facts
Active substance
apixaban
Drug class
Direct Xa inhibitor
ATC code
B01AF02
Authorisation
centrally authorised across the EU (EMA)
Dosage forms
Eliquis 2.5 mg film-coated tablets · Eliquis 5 mg film-coated tablets · Eliquis 0.15 mg granules in capsules for opening · Eliquis 0.5 mg coated granule in sachet / Eliquis 1.5 mg coated granules in sachet / Eliquis 2 mg coated granules in sachet
Marketing authorisation holder
Bristol-Myers Squibb / Pfizer EEIG
Information as of
2026-10-27

Key facts

Apixaban is an oral direct factor Xa inhibitor (anticoagulant). It is used to prevent and treat venous thromboembolism and to prevent stroke in non-valvular atrial fibrillation.

What it is used for

  • Prevention of venous thromboembolic events (VTE) in adults after elective hip or knee replacement surgery (2.5 mg tablets)
  • Prevention of stroke and systemic embolism in adults with non-valvular atrial fibrillation (NVAF) and one or more risk factors
  • Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and prevention of recurrent DVT and PE in adults
  • Paediatric patients from 28 days to less than 18 years: treatment of VTE and prevention of recurrent VTE

Dosing

  • VTE prevention after hip/knee replacement: 2.5 mg twice daily, first dose 12 to 24 hours after surgery; 32 to 38 days (hip) or 10 to 14 days (knee)
  • NVAF: 5 mg twice daily, continued long-term
  • NVAF dose reduction to 2.5 mg twice daily with at least two of: age ≥ 80 years, body weight ≤ 60 kg, serum creatinine ≥ 1.5 mg/dL
  • Acute DVT/PE: 10 mg twice daily for the first 7 days, then 5 mg twice daily
  • Prevention of recurrent DVT/PE after 6 months of treatment: 2.5 mg twice daily
  • Children: weight-tiered dosing after at least 5 days of parenteral anticoagulation; granule forms for patients < 35 kg; details in the full text

Contraindications

  • Hypersensitivity to the active substance or any excipient
  • Active clinically significant bleeding
  • Hepatic disease associated with coagulopathy and clinically relevant bleeding risk
  • Lesions or conditions that are a significant risk factor for major bleeding (e.g. current gastrointestinal ulceration, recent intracranial haemorrhage)
  • Concomitant treatment with any other anticoagulant

Important warnings

  • Haemorrhage risk: observe carefully for signs of bleeding; discontinue if severe haemorrhage occurs
  • A specific reversal agent (andexanet alfa) is available for adults; its safety and efficacy are not established in children
  • Concomitant antiplatelet agents increase the risk of bleeding
  • No routine exposure monitoring is required; a calibrated anti-factor Xa assay may help in exceptional situations such as overdose or emergency surgery

Side effects

  • Common: haemorrhage, contusion, epistaxis and haematoma
  • Major bleeding, including gastrointestinal and intraocular bleeding, has been reported

Interactions

  • Strong inhibitors of both CYP3A4 and P-gp (e.g. ketoconazole, itraconazole, voriconazole, posaconazole, ritonavir): concomitant systemic use not recommended
  • Ketoconazole led to a 2-fold increase in mean apixaban AUC
  • Other anticoagulants are contraindicated; antiplatelet agents increase bleeding risk

Pregnancy and breastfeeding

  • Pregnancy: no human data; as a precaution, use during pregnancy should preferably be avoided
  • Breast-feeding: excretion in human milk unknown (shown in animals); a decision is needed to stop breast-feeding or stop/abstain from therapy

Summary of the official product information, written with AI (Claude, Anthropic) on 2026-10-28. Every number was checked automatically against the original text. Not reviewed by a physician – the full official text is authoritative.

Full official text →

Common questions – ask Medelix

For patients

Package leaflet, verbatim

Package leaflet for patients →

Authorisation and brand names by country

Medicines with exactly this active-substance composition, as listed in the national registers – alphabetical and without ranking. Whether a product is currently available is not shown here.

EU – centrally authorised (all member states)

  • Apixaban Accord · genericAccord Healthcare S.L.U. · EMEA/H/C/005358
  • EliquisBristol-Myers Squibb / Pfizer EEIG · EMEA/H/C/002148

Source: European Medicines Agency (EMA), product information

Austria

  • AbatixentSandoz Gmbh · 1 register entry
  • Apixaban1a Pharma Gmbh, Viatris Limited, Ratiopharm Arzneimittel Vertriebs-Gmbh, Genericon Pharma Gesellschaft M.B.H., Glenmark Arzneimittel Gmbh, Grindeks, +pharma Arzneimittel Gmbh, Devatis Gmbh, Zentiva, K.S., Biocon Pharma Malta I Limited, Sandoz Gmbh, Hexal Pharma Gmbh, Reddy Holding Gmbh, Stada Arzneimittel Gmbh, Denk Pharma Gmbh & Co. Kg, Hcs Bvba · 17 register entries
  • ElihibG.L. Pharma Gmbh · 1 register entry
  • PicsavaSteden Pharma B.V. · 1 register entry
  • SewabSandoz Gmbh · 1 register entry

Source: EMA – Article 57 product data (EU/EEA), as of 2026-10-28

Germany

  • Abidalo123 Acurae Pharma Gmbh · 1 register entry
  • AkkirateronDay Zero Ehf · 1 register entry
  • ApixabanBasics Gmbh, Betapharm Arzneimittel Gmbh, Reddy Holding Gmbh, 089pharm Gmbh, 1 A Pharma Gmbh, Towa Pharmaceutical Europe S.L., Viatris Limited, Aet, De, Ethypharm, Aaa-Pharma Gmbh, Micro Labs Gmbh, Ratiopharm Gmbh, Aenorasis S.A., Puren Pharma Gmbh & Co. Kg, Medical Valley Invest Ab, Glenmark Arzneimittel Gmbh, Grindeks, Hormosan Pharma Gmbh, Macleods Pharma España, S.L.U, Devatis Gmbh, Heumann Pharma Gmbh & Co. Generica Kg, Vivanta Generics S.R.O., Zentiva Pharma Gmbh, Adamed Pharma S.A., Amarox Pharma Gmbh, Aristo Pharma Gmbh (Art 57), Nio Health Gmbh, Indoco Remedies Czech S.R.O., Cipla Europe Nv, Intas Third Party Sales 2005, S.L., Viatris Germany Gmbh, Olpha As, Stadapharm Gmbh, Abdi Farma Gmbh, Denk Pharma Gmbh & Co. Kg, Juta Pharma Gmbh, Abz-Pharma Gmbh, Hec Pharm Gmbh, Tad Pharma Gmbh, Aliud Pharma Gmbh · 43 register entries
  • AxipioStada Arzneimittel Ag · 1 register entry
  • EmbaviEgis Pharmaceuticals Plc · 1 register entry
  • PicsavaPharmapath Sa, Maddox Pharma Swiss Gmbh · 3 register entries
  • TrefteninDay Zero Ehf · 2 register entries

Source: EMA – Article 57 product data (EU/EEA), as of 2026-10-28

Turkey

  • ApaclotDEVA HOLDİNG A.Ş. · 3 register entries
  • ApeltoATABAY KİMYA SAN. VE TİC. A.Ş. · 4 register entries
  • ApivoraHUMANİS SAĞLIK A.Ş. · 6 register entries
  • ApixelisDEM İLAÇ SAN. VE TİC. A.Ş. · 4 register entries
  • ApixentaABDİ İBRAHİM İLAÇ SAN. VE TİC. A.Ş. · 4 register entries
  • AtenicSANOVEL İLAÇ SAN. VE TİC. A.Ş. · 6 register entries
  • EliquisPFİZER PFE İLAÇLARI A.Ş. · 6 register entries
  • ElixabanAPİANA ÖZEL SAĞLIK MEDİKAL GIDA TEKSTİL ELEKTRİK DEKORASYON KOZMETİK İTH. İHR. SAN. VE TİC. LTD. ŞTİ. · 4 register entries
  • EqutrabanBİOFARMA İLAÇ SAN. VE TİC. A.Ş. · 2 register entries
  • OlpixaOLPHA İLAÇ VE TIBBİ ÜRÜNLER SAN. VE TİC. LTD. ŞTİ. · 4 register entries
  • PaxibanNOBEL İLAÇ SAN. VE TİC. A.Ş. · 6 register entries
  • TromboxarALİ RAİF İLAÇ SAN. A.Ş. · 6 register entries
Show all 15 brand names
  • VaxivoSANTA FARMA İLAÇ SAN. A.Ş. · 6 register entries
  • XaprevVİATRİS İLAÇLARI LİMİTED ŞİRKETİ · 6 register entries
  • ZavionyxWORLD MEDICINE İLAÇ SAN. VE TİC. A.Ş. · 5 register entries

Source: TİTCK – Ruhsatlı Beşeri Tıbbi Ürünler Listesi, as of 2026-10-16

Brand names in 28 more European countries
Belgium
Apixaban Ab, Apixaban Eg, Apixaban Generics Teva, Apixaban Grindeks, Apixaban Krka, Apixaban Sandoz, Apixaban Teva, Apixaban Viatris, Apixlets
Bulgaria
Abatixent, Apixaban, Apixagamma, Абоксома, Авоклод, Апиксабан, Апиксан, Возиберин, Елихиб, Ембави, Ксалпебон, Паксибан, Пиксанел, Полапикс
Croatia
Abatixent, Abidalo, Aboxoma, Apaksy, Apiksaban Abela, Apiksaban Frontier, Apiksaban Genericon, Apiksaban Grindeks, Apiksaban Hcs, Apiksaban Krka, Apiksaban Teva, Avoclod, Axipio, Banxiol, Bapesan, Elyes, Frontier, Fydoco, Siargena, Voziberin
Cyprus
Abidalo, Apixaban, Bifized, Lunast, Venixan, Xalpebon
Czechia
Aboxoma, Apixaban, Avoclod, Elihib, Elyes, Embavi, Polapix, Prubdaq, Voziberin, Xalpebon, Zelinared
Denmark
Apinovia, Apixaban "liconsa", Apixaban "sandoz", Apixaban Axunio, Apixaban Cipla, Apixaban Glenmark, Apixaban Grindeks, Apixaban Juta, Apixaban Krka, Apixaban Medical Valley, Apixaban Orion, Apixaban Stada, Apixaban Teva, Apixaban Viatris, Apixaban Vivanta, Apixaban Zentiva, Apixerin, Apixlets, Apobilen, Baxiren, Pibaxin, Picsava, Zvelga
Estonia
Abatixent, Aboxoma, Apixaban, Banxiol, Prubdaq, Venixan, Voziberin, Xalpebon, Zelinared
Finland
Apiclodem, Apixaban, Elihib, Fydoco, Sisla, Sislaf
France
Apixaban, Sewab
Greece
Abixatec, Aboxoma, Apiclodem, Apinovia, Apixaban, Apixlets, Avoclod, Bifized, Elipticus, Pibaxin, Pixafib, Prepixan, Siargena, Sislaf, Thrombax®, Xalpebon, Xamera, Zekuis, Zinbix
Hungary
Aboxoma, Apixaban, Avoclod, Baxiren, Embavi, Prubdaq, Voziberin
Iceland
Apixaban Accord, Apixaban Krka, Apixaban Medical Valley, Apixaban Sandoz, Apixaban Stada, Apixaban Teva, Apixaban Viatris, Apixaban Wh, Apixaban Zentiva, Eliquis
Ireland
Apixaban Abdi, Apixaban Aristo, Apixaban Clonmel, Apixaban Grindeks, Apixaban Krka, Apixaban Msn, Apixaban Pinewood Laboratories, Apixaban Renata Pharmaceuticals (Ireland), Apixaban Rowa, Apixaban Rowex, Apixaban Teva, Apixaban Viatris, Arinaya
Italy
Apilion, Apixaban Abdi, Apixaban Adamed, Apixaban Alter, Apixaban Aurobindo, Apixaban Biocon, Apixaban Bruno Farmaceutici, Apixaban Cipla, Apixaban Doc, Apixaban Dr. Reddys, Apixaban Eg, Apixaban Ever Pharma, Apixaban Glenmark, Apixaban Grindeks, Apixaban Hcs, Apixaban Laboratori Alter, Apixaban Mylan, Apixaban Olpha, Apixaban Pensa, Apixaban Sandoz, Apixaban Sun, Apixaban Tecnigen, Apixaban Teva, Apixaban Vi.Rel Pharma, Apixaban Viatris Pharma, Apixaban Vivanta, Apixaban Zentiva, Banxan, Elihib, Erimpox, Opixaf, Pixadil
Latvia
Abatixent, Aboxoma, Apixaban Adoh, Apixaban Grindeks, Apixaban Olpha, Apixaban Sandoz, Apixaban Stada, Apixaban Teva, Apixaban Viatris, Apixaban Zentiva, Embavi, Venixan, Voziberin, Xalpebon
Liechtenstein
Apixaban Accord, Eliquis
Lithuania
Abatixent, Aboxoma, Apixaban, Embavi, Prubdaq, Voziberin
Luxembourg
Apixaban Eg, Apixaban Ratiopharm, Apixaban Viatris, Apixlets
Malta
Abidalo, Antixara, Apixaban Alembic, Apixaban Combino Pharm, Apixaban Denk, Apixaban Iasis, Apixaban Medichem, Apixaban Mylan, Apixaban Renata Pharmaceuticals (Ireland), Apixaban Viatris, Apixaban Zentiva, Apixerin, Pibaxin, Venixan, Zinbix
Netherlands
Abatixent, Apilion, Apixaban, Apixabán Macleods, Bifized, Opixaf, Prepixan, Sewab, Vanclotiban
Norway
Apixaban Accord, Apixaban Axunio, Apixaban Cipla, Apixaban Glenmark, Apixaban Grindeks, Apixaban Indoco, Apixaban Krka, Apixaban Medical Valley, Apixaban Orion, Apixaban Sandoz, Apixaban Teva, Apixaban Viatris, Apixaban Vivanta, Apixaban Zentiva, Eliquis
Poland
Abatixent, Aboxoma, Antixara, Apinoptim, Apixaban, Apixabanum Teva, Apixil, Avoclod, Axipio, Banxiol, Baxiren, Elihib, Embavi, Erimpox, Fydoco, Poltixa, Prubdaq, Treftenin, Voziberin, Vyselik, Zelinared
Portugal
Apixaban Grindeks, Apixabano Alter, Apixabano Aquizent, Apixabano Aurovitas, Apixabano Azevedos, Apixabano Biofarmoz, Apixabano Bluepharma, Apixabano Bravet, Apixabano Fantex, Apixabano Farmoz, Apixabano Generis, Apixabano Grindeks, Apixabano Hoxyo, Apixabano Humanis, Apixabano Krka, Apixabano Mylan, Apixabano Odipe, Apixabano Pentafarma, Apixabano Pharmakern, Apixabano Pharmazac, Apixabano Ratiopharm, Apixabano Sandoz, Apixabano Stada, Apixabano Tad, Apixabano Tecnigen, Apixabano Teva, Apixabano Tolife, Apixabano Torrent, Apixabano Towa Pharmaceutical Europe, Apixabano Viatris Pharma, Apixabano Vitória, Apixabano Zentiva, Banrix, Erimpox, Venixan, Zinbix
Romania
Abatixent, Aboxoma, Apixaban, Avoclod, Banxiol, Bifized, Embavi, Fydoco, Lyxaro, Venixan, Voziberin
Slovakia
Aboxoma, Apixaban, Avoclod, Elyes, Embavi, Prubdaq, Sislaf, Voziberin, Xalpebon, Zelinared
Slovenia
Abatixent, Aboxoma, Apaksy, Apiksaban Stada, Apiksaban Teva, Apiksaban Viatris Pharma, Apixaban Grindeks, Banxiol, Elyes, Fydoco, Voziberin
Spain
Apicassa, Apiclot, Apixaban, Apixabán Adamed, Apixabán Almus, Apixabán Alter Genéricos, Apixabán Aurovitas, Apixabán Cinfa, Apixabán Cinfamed, Apixabán Farmalider, Apixabán Gobens, Apixabán Kern Pharma, Apixabán Lek-Am, Apixabán Newline Pharma, Apixabán Normogen, Apixabán Normon, Apixabán Olpha, Apixabán Pensa, Apixabán Premium Pharma, Apixabán Rovi, Apixabán Stada, Apixabán Tarbis, Apixabán Tecnigen, Apixabán Teva, Apixabán Torrent, Apixabán Viso Farmacéutica, Apixabán Vivanta, Apixabán Zentiva, Apobilen, Arinaya, Cloter, Elibax, Erimpox, Fydoco, Garoxan, Sabexan
Sweden
Apixaban, Voziberin

EMA – Article 57 product data (EU/EEA), 2026-10-28

Medelix receives no money from pharmaceutical companies. Brand names are listed alphabetically and without ranking.

Other substances in the same group

Related calculators

Another question about this substance?

Medelix answers clinical questions from guidelines, studies and product information – every claim with its source.

Sources

  1. European Medicines Agency. Eliquis – EPAR, Product Information (OF THE TEXT Detailed information on this medicinal product i). 2026-10-27. https://www.ema.europa.eu/en/documents/product-information/eliquis-epar-product-information_en.pdf
  2. EMA – Article 57 product data (EU/EEA), 2026-10-28. https://www.ema.europa.eu/en/human-regulatory-overview/post-authorisation/data-medicines-iso-idmp-standards-post-authorisation/public-data-article-57-database
  3. EMA – Article 57 product data (EU/EEA), 2026-10-28. https://www.ema.europa.eu/en/human-regulatory-overview/post-authorisation/data-medicines-iso-idmp-standards-post-authorisation/public-data-article-57-database
  4. TİTCK – Ruhsatlı Beşeri Tıbbi Ürünler Listesi, 2026-10-16. https://www.titck.gov.tr/dinamikmodul/85
  5. Wikidata (CC0): ATC B01AF.

Editorial: Medelix editorial team · last updated 2026-10-27 · How these pages are made · Report an error

Source: European Medicines Agency (EMA), product information. Not advertising, not a treatment recommendation. For questions about your own treatment, ask your doctor or pharmacist.